Optina Diagnostics Overview
- Founded
- 2011
- Status
- Private
- Employees
- 27
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $2.1M
- Investors
- 19
Optina Diagnostics General Information
Description
Developer of ocular imaging systems and diagnostic tools designed to help detect key biomarkers of Alzheimer's diseases. The company's imaging systems detect age-related macular degeneration and ocular diabetic retinopathy and identify beta-amyloid (AB) plaques, enabling doctors to detect and treat eye-related diseases.
Contact Information
Website
www.optinadx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
- 8200 Décarie Boulevard
- Suite 220
- Montreal, Quebec H4P 2P5
- Canada
+1 (514) 000-0000
Optina Diagnostics Timeline
Optina Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 24-Jan-2022 | $2.1M | 000.00 | Completed | Generating Revenue | |
| 10. Later Stage VC (Series A) | 28-Oct-2021 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 9. Later Stage VC | 20-Jun-2020 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 8. Later Stage VC | 12-Jun-2019 | 00.000 | Completed | Generating Revenue | ||
| 7. Seed Round | 10-Oct-2018 | 00.000 | 00.000 | Completed | Clinical Trials - Phase 3 | |
| 6. Accelerator/Incubator | 22-Jan-2018 | 00000 | Completed | Clinical Trials - Phase 3 | ||
| 5. Debt - General | 31-Dec-2017 | 00000 | 00000 | Completed | Startup | |
| 4. Accelerator/Incubator | 16-Oct-2016 | 00000 | 00000 | Completed | Startup | |
| 3. Grant | 27-May-2015 | $1.63M | Completed | Startup | ||
| 2. Grant | 21-Nov-2014 | $233K | Completed | Startup |
Optina Diagnostics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of ocular imaging systems and diagnostic tools designed to help detect key biomarkers of Alzheimer's diseases.
Other Healthcare Technology Systems
Montreal, Canada
27
As of 2022
000.00
0000000000 0
000.00
00000 00
velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
00000 0000000000 0000000000 0000000
Boston, MA
000
As of 0000
00000
000000000
00000
0000000
o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
0000000000 000000000
Rehovot, Israel
00
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOptina Diagnostics Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Akili Interactive | Venture Capital-Backed | Boston, MA | 000 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Rehovot, Israel | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Venture Capital-Backed | Cambridge, United Kingdom | 0 | 00.00 | 0000000000 0 | 00.00 |
Optina Diagnostics Patents
Optina Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3134081-A1 | Method and system for identifying subjects who are potentially impacted by a medical condition | Pending | 19-Mar-2019 | 000000000 | |
| US-20210201514-A1 | Method and system for imaging a biological tissue | Pending | 20-Oct-2016 | 000000000 | |
| JP-2020504289-A | Method and system for detecting abnormalities in biological tissue | Pending | 20-Oct-2016 | 000000000 | |
| CA-3039858-A1 | Method and system for detecting an anomaly within a biological tissue | Pending | 20-Oct-2016 | 00000000 | |
| EP-3529591-B1 | Method and system for detecting an anomaly within a biological tissue | Active | 20-Oct-2016 | G06T7/40 |
Optina Diagnostics Executive Team (5)
Optina Diagnostics Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Lapointe | Optina Diagnostics | Co-Founder, Chief Executive Officer, Board Member & President | 000 0000 |
| Jacques Dessureault | Self | Board Member | 000 0000 |
| Marc Rivière MD | Self | Board Observer | 000 0000 |
| Marie-Agnes Chavane | Desjardins Capital | Board Observer | 000 0000 |
| Neal Mody | Self | Board Member & Advisor | 000 0000 |
Optina Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOptina Diagnostics Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| Alfin | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Boehringer Ingelheim Venture Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| MEDTEQ Invest | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| Advisors.Fund | Venture Capital | Minority | 000 0000 | 000000 0 |